Michael Terpstra has held various strategic and leadership roles in pharmaceutical companies such as Pfizer and Affimed. Michael played a key role in developing strategies for new product launches, therapeutic area strategies, and identifying business development opportunities. With a background in economics and finance, Michael has a strong track record of driving growth and making strategic recommendations that have positively impacted the business.
March, 2022 - present
April, 2019